{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:53:44Z","timestamp":1793969624159,"version":"4.8.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA190688"],"award-info":[{"award-number":["R01CA190688"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA236911"],"award-info":[{"award-number":["R01CA236911"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL136432"],"award-info":[{"award-number":["R01HL136432"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"DOI":"10.13039\/100011305","name":"UAB | Comprehensive Cancer Center, University of Alabama at Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011221","name":"UAB | School of Medicine, University of Alabama at Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011221","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UAB, Department of Pathology"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41417-020-00262-9","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T09:02:44Z","timestamp":1606467764000},"page":"1000-1015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia"],"prefix":"10.1038","volume":"28","author":[{"given":"Lana","family":"Vukadin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua K.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ungerleider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody C.","family":"Baddoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Kyung","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik K.","family":"Flemington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0323-8607","authenticated-orcid":false,"given":"Ssang-Taek Steve","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8795-7734","authenticated-orcid":false,"given":"Eun-Young Erin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"262_CR1","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/sj.leu.2402618","volume":"16","author":"L Pagano","year":"2002","unstructured":"Pagano L, Pulsoni A, Vignetti M, Mele L, Fianchi L, Petti MC, et al. Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia. 2002;16:1622\u20136.","journal-title":"Leukemia"},{"key":"262_CR2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.2000.02027.x","volume":"110","author":"B Lange","year":"2000","unstructured":"Lange B. The management of neoplastic disorders of haematopoiesis in children with Down\u2019s syndrome. Br J Haematol. 2000;110:512\u201324.","journal-title":"Br J Haematol"},{"key":"262_CR3","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood.V97.12.3727","volume":"97","author":"UH Athale","year":"2001","unstructured":"Athale UH, Razzouk BI, Raimondi SC, Tong X, Behm FG, Head DR, et al. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution\u2019s experience. Blood. 2001;97:3727\u201332.","journal-title":"Blood"},{"key":"262_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pbc.20951","volume":"49","author":"DR Barnard","year":"2007","unstructured":"Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG. Children\u2019s Oncology G. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2007;49:17\u201322.","journal-title":"Pediatr Blood Cancer"},{"key":"262_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1525","volume":"5","author":"JK Hitzler","year":"2005","unstructured":"Hitzler JK, Zipursky A. Origins of leukaemia in children with Down syndrome. Nat Rev Cancer. 2005;5:11\u201320.","journal-title":"Nat Rev Cancer"},{"key":"262_CR6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood-2015-05-567859","volume":"126","author":"TA Gruber","year":"2015","unstructured":"Gruber TA, Downing JR. The biology of pediatric acute megakaryoblastic leukemia. Blood. 2015;126:943\u20139.","journal-title":"Blood"},{"key":"262_CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjh.13096","volume":"167","author":"I Roberts","year":"2014","unstructured":"Roberts I, Izraeli S. Haematopoietic development and leukaemia in Down syndrome. Br J Haematol. 2014;167:587\u201399.","journal-title":"Br J Haematol"},{"key":"262_CR8","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2008-05-157859","volume":"112","author":"ST Chou","year":"2008","unstructured":"Chou ST, Opalinska JB, Yao Y, Fernandes MA, Kalota A, Brooks JS, et al. Trisomy 21 enhances human fetal erythro-megakaryocytic development. Blood. 2008;112:4503\u20136.","journal-title":"Blood"},{"key":"262_CR9","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1182\/blood-2008-04-152967","volume":"112","author":"O Tunstall-Pedoe","year":"2008","unstructured":"Tunstall-Pedoe O, Roy A, Karadimitris A, de la Fuente J, Fisk NM, Bennett P, et al. Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood. 2008;112:4507\u201311.","journal-title":"Blood"},{"key":"262_CR10","doi-asserted-by":"crossref","first-page":"17573","DOI":"10.1073\/pnas.1211175109","volume":"109","author":"ST Chou","year":"2012","unstructured":"Chou ST, Byrska-Bishop M, Tober JM, Yao Y, Vandorn D, Opalinska JB, et al. Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc Natl Acad Sci USA. 2012;109:17573\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"262_CR11","doi-asserted-by":"crossref","first-page":"17579","DOI":"10.1073\/pnas.1211405109","volume":"109","author":"A Roy","year":"2012","unstructured":"Roy A, Cowan G, Mead AJ, Filippi S, Bohn G, Chaidos A, et al. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci USA. 2012;109:17579\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"262_CR12","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1073\/pnas.0813248106","volume":"106","author":"JO Korbel","year":"2009","unstructured":"Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L, et al. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci USA. 2009;106:12031\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"262_CR13","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1038\/onc.2010.351","volume":"29","author":"S De Vita","year":"2010","unstructured":"De Vita S, Canzonetta C, Mulligan C, Delom F, Groet J, Baldo C, et al. Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down\u2019s syndrome. Oncogene. 2010;29:6102\u201314.","journal-title":"Oncogene"},{"key":"262_CR14","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1158\/0008-5472.CAN-09-0075","volume":"69","author":"S Salek-Ardakani","year":"2009","unstructured":"Salek-Ardakani S, Smooha G, de Boer J, Sebire NJ, Morrow M, Rainis L, et al. ERG is a megakaryocytic oncogene. Cancer Res. 2009;69:4665\u201373.","journal-title":"Cancer Res"},{"key":"262_CR15","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1182\/blood-2008-08-174813","volume":"113","author":"MJ Stankiewicz","year":"2009","unstructured":"Stankiewicz MJ, Crispino JD. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells. Blood. 2009;113:3337\u201347.","journal-title":"Blood"},{"key":"262_CR16","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1182\/blood-2009-09-242107","volume":"115","author":"AP Ng","year":"2010","unstructured":"Ng AP, Hyland CD, Metcalf D, Carmichael CL, Loughran SJ, Di Rago L, et al. Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. Blood. 2010;115:3966\u20139.","journal-title":"Blood"},{"key":"262_CR17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1172\/JCI60455","volume":"122","author":"S Malinge","year":"2012","unstructured":"Malinge S, Bliss-Moreau M, Kirsammer G, Diebold L, Chlon T, Gurbuxani S, et al. Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome. J Clin Investig. 2012;122:948\u201362.","journal-title":"J Clin Investig"},{"key":"262_CR18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1101\/gad.1856210","volume":"24","author":"JH Klusmann","year":"2010","unstructured":"Klusmann JH, Li Z, Bohmer K, Maroz A, Koch ML, Emmrich S, et al. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev. 2010;24:478\u201390.","journal-title":"Genes Dev"},{"key":"262_CR19","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1073\/pnas.0511150103","volume":"103","author":"JP Bourquin","year":"2006","unstructured":"Bourquin JP, Subramanian A, Langebrake C, Reinhardt D, Bernard O, Ballerini P, et al. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci USA. 2006;103:3339\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"262_CR20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jcb.24672","volume":"115","author":"CJ Hickey","year":"2014","unstructured":"Hickey CJ, Kim JH, Ahn EY. New discoveries of old SON: a link between RNA splicing and cancer. J Cell Biochem. 2014;115:224\u201331.","journal-title":"J Cell Biochem"},{"key":"262_CR21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2011.03.014","volume":"42","author":"EY Ahn","year":"2011","unstructured":"Ahn EY, DeKelver RC, Lo MC, Nguyen TA, Matsuura S, Boyapati A, et al. SON controls cell-cycle progression by coordinated regulation of RNA splicing. Mol Cell. 2011;42:185\u201398.","journal-title":"Mol Cell"},{"key":"262_CR22","doi-asserted-by":"crossref","first-page":"24059","DOI":"10.1074\/jbc.M101330200","volume":"276","author":"CT Sun","year":"2001","unstructured":"Sun CT, Lo WY, Wang IH, Lo YH, Shiou SR, Lai CK, et al. Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein\/SON. J Biol Chem. 2001;276:24059\u201367.","journal-title":"J Biol Chem"},{"key":"262_CR23","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1074\/jbc.M112.447227","volume":"288","author":"EE Ahn","year":"2013","unstructured":"Ahn EE, Higashi T, Yan M, Matsuura S, Hickey CJ, Lo MC, et al. SON protein regulates GATA-2 through transcriptional control of the microRNA 23a~27a~24-2 cluster. J Biol Chem. 2013;288:5381\u20138.","journal-title":"J Biol Chem"},{"key":"262_CR24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ncb2839","volume":"15","author":"X Lu","year":"2013","unstructured":"Lu X, Goke J, Sachs F, Jacques PE, Liang H, Feng B, et al. SON connects the splicing-regulatory network with pluripotency in human embryonic stem cells. Nat Cell Biol. 2013;15:1141\u201352.","journal-title":"Nat Cell Biol"},{"key":"262_CR25","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1242\/jcs.092239","volume":"124","author":"A Sharma","year":"2011","unstructured":"Sharma A, Markey M, Torres-Munoz K, Varia S, Kadakia M, Bubulya A, et al. Son maintains accurate splicing for a subset of human pre-mRNAs. J Cell Sci. 2011;124:4286\u201398.","journal-title":"J Cell Sci"},{"key":"262_CR26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ajhg.2016.06.029","volume":"99","author":"JH Kim","year":"2016","unstructured":"Kim JH, Shinde DN, Reijnders MRF, Hauser NS, Belmonte RL, Wilson GR, et al. De novo mutations in SON disrupt RNA splicing of genes essential for brain development and metabolism, causing an intellectual-disability syndrome. Am J Hum Genet. 2016;99:711\u20139.","journal-title":"Am J Hum Genet"},{"key":"262_CR27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF00360539","volume":"101","author":"T Mattioni","year":"1992","unstructured":"Mattioni T, Hume CR, Konigorski S, Hayes P, Osterweil Z, Lee JS. A cDNA clone for a novel nuclear protein with DNA binding activity. Chromosoma. 1992;101:618\u201324.","journal-title":"Chromosoma"},{"key":"262_CR28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molcel.2016.02.024","volume":"61","author":"JH Kim","year":"2016","unstructured":"Kim JH, Baddoo MC, Park EY, Stone JK, Park H, Butler TW, et al. SON and its alternatively spliced isoforms control MLL complex-mediated H3K4me3 and transcription of leukemia-associated genes. Mol Cell. 2016;61:859\u201373.","journal-title":"Mol Cell"},{"key":"262_CR29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016;34:525\u20137.","journal-title":"Nat Biotechnol"},{"key":"262_CR30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth.4324","volume":"14","author":"H Pimentel","year":"2017","unstructured":"Pimentel H, Bray NL, Puente S, Melsted P, Pachter L. Differential analysis of RNA-seq incorporating quantification uncertainty. Nat Methods. 2017;14:687\u201390.","journal-title":"Nat Methods"},{"key":"262_CR31","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"262_CR32","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"262_CR33","doi-asserted-by":"crossref","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","volume":"44","author":"FO Bagger","year":"2016","unstructured":"Bagger FO, Sasivarevic D, Sohi SH, Laursen LG, Pundhir S, Sonderby CK, et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 2016;44:D917\u2013924.","journal-title":"Nucleic Acids Res"},{"key":"262_CR34","doi-asserted-by":"crossref","first-page":"1251033","DOI":"10.1126\/science.1251033","volume":"345","author":"L Chen","year":"2014","unstructured":"Chen L, Kostadima M, Martens JHA, Canu G, Garcia SP, Turro E, et al. Transcriptional diversity during lineage commitment of human blood progenitors. Science. 2014;345:1251033.","journal-title":"Science"},{"key":"262_CR35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","volume":"35","author":"E Wang","year":"2019","unstructured":"Wang E, Lu SX, Pastore A, Chen X, Imig J, Chun-Wei Lee S, et al. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell. 2019;35:369\u201384. e367","journal-title":"Cancer Cell"},{"key":"262_CR36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1101\/gad.1903410","volume":"24","author":"JH Klusmann","year":"2010","unstructured":"Klusmann JH, Godinho FJ, Heitmann K, Maroz A, Koch ML, Reinhardt D, et al. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev. 2010;24:1659\u201372.","journal-title":"Genes Dev"},{"key":"262_CR37","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1182\/bloodadvances.2019030981","volume":"3","author":"S Cardin","year":"2019","unstructured":"Cardin S, Bilodeau M, Roussy M, Aubert L, Milan T, Jouan L, et al. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities. Blood Adv. 2019;3:3307\u201321.","journal-title":"Blood Adv"},{"key":"262_CR38","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1172\/JCI114538","volume":"85","author":"MW Long","year":"1990","unstructured":"Long MW, Heffner CH, Williams JL, Peters C, Prochownik EV. Regulation of megakaryocyte phenotype in human erythroleukemia cells. J Clin Investig. 1990;85:1072\u201384.","journal-title":"J Clin Investig"},{"key":"262_CR39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1242\/jcs.101.3.671","volume":"101","author":"BA Hocevar","year":"1992","unstructured":"Hocevar BA, Morrow DM, Tykocinski ML, Fields AP. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation. J Cell Sci. 1992;101:671\u20139.","journal-title":"J Cell Sci"},{"key":"262_CR40","first-page":"501","volume":"11","author":"C Shelly","year":"2000","unstructured":"Shelly C, Petruzzelli L, Herrera R. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation. Cell Growth Differ. 2000;11:501\u20136.","journal-title":"Cell Growth Differ"},{"key":"262_CR41","doi-asserted-by":"crossref","first-page":"23366","DOI":"10.1074\/jbc.272.37.23366","volume":"272","author":"FK Racke","year":"1997","unstructured":"Racke FK, Lewandowska K, Goueli S, Goldfarb AN. Sustained activation of the extracellular signal-regulated kinase\/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J Biol Chem. 1997;272:23366\u201370.","journal-title":"J Biol Chem"},{"key":"262_CR42","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.4049\/jimmunol.1500719","volume":"196","author":"H Jiang","year":"2016","unstructured":"Jiang H, Promchan K, Lin BR, Lockett S, Chen D, Marshall H, et al. LZTFL1 upregulated by all-trans retinoic acid during CD4+ T cell activation enhances IL-5 production. J Immunol. 2016;196:1081\u201390.","journal-title":"J Immunol"},{"key":"262_CR43","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3324\/haematol.2019.216861","volume":"104","author":"H Kato","year":"2019","unstructured":"Kato H, Igarashi K. To be red or white: lineage commitment and maintenance of the hematopoietic system by the \u201cinner myeloid\u201d. Haematologica. 2019;104:1919\u201327.","journal-title":"Haematologica"},{"key":"262_CR44","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.celrep.2017.02.029","volume":"18","author":"A Itoh-Nakadai","year":"2017","unstructured":"Itoh-Nakadai A, Matsumoto M, Kato H, Sasaki J, Uehara Y, Sato Y, et al. A Bach2-Cebp gene regulatory network for the commitment of multipotent hematopoietic progenitors. Cell Rep. 2017;18:2401\u201314.","journal-title":"Cell Rep"},{"key":"262_CR45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2008.11.065","volume":"381","author":"T Hamada","year":"2009","unstructured":"Hamada T, Murasawa S, Yokoyama A, Hayashi S, Kobayashi Y, Asahara T. Changing modified regions in the genome in hematopoietic stem cell differentiation. Biochem Biophys Res Commun. 2009;381:135\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"262_CR46","doi-asserted-by":"crossref","first-page":"30138","DOI":"10.18632\/oncotarget.15619","volume":"8","author":"J Fan","year":"2017","unstructured":"Fan J, Wang Y, Shen Y, Liu Q, Gao R, Qiu Y, et al. A novel role of CKIP-1 in promoting megakaryocytic differentiation. Oncotarget. 2017;8:30138\u201350.","journal-title":"Oncotarget"},{"key":"262_CR47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1189\/jlb.0107014","volume":"82","author":"XL Liu","year":"2007","unstructured":"Liu XL, Yuan JY, Zhang JW, Zhang XH, Wang RX. Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage. J Leukoc Biol. 2007;82:986\u20131002.","journal-title":"J Leukoc Biol"},{"key":"262_CR48","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1182\/blood.2019000185","volume":"134","author":"S Geue","year":"2019","unstructured":"Geue S, Aurbach K, Manke MC, Manukjan G, Munzer P, Stegner D, et al. Pivotal role of PDK1 in megakaryocyte cytoskeletal dynamics and polarization during platelet biogenesis. Blood. 2019;134:1847\u201358.","journal-title":"Blood"},{"key":"262_CR49","doi-asserted-by":"crossref","first-page":"e78780","DOI":"10.1371\/journal.pone.0078780","volume":"8","author":"E Vakana","year":"2013","unstructured":"Vakana E, Arslan AD, Szilard A, Altman JK, Platanias LC. Regulatory effects of sestrin 3 (SESN3) in BCR-ABL expressing cells. PLoS ONE. 2013;8:e78780.","journal-title":"PLoS ONE"},{"key":"262_CR50","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/jth.12359","volume":"11","author":"YA Senis","year":"2013","unstructured":"Senis YA. Protein-tyrosine phosphatases: a new frontier in platelet signal transduction. J Thromb Haemost. 2013;11:1800\u201313.","journal-title":"J Thromb Haemost"},{"key":"262_CR51","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1182\/blood-2006-07-037838","volume":"109","author":"H Raslova","year":"2007","unstructured":"Raslova H, Kauffmann A, Sekkai D, Ripoche H, Larbret F, Robert T, et al. Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach. Blood. 2007;109:3225\u201334.","journal-title":"Blood"},{"key":"262_CR52","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","volume":"394","author":"ML Kahn","year":"1998","unstructured":"Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, et al. A dual thrombin receptor system for platelet activation. Nature. 1998;394:690\u20134.","journal-title":"Nature"},{"key":"262_CR53","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2018-07-859496","volume":"133","author":"C Marconi","year":"2019","unstructured":"Marconi C, Di Buduo CA, LeVine K, Barozzi S, Faleschini M, Bozzi V, et al. Loss-of-function mutations in PTPRJ cause a new form of inherited thrombocytopenia. Blood. 2019;133:1346\u201357.","journal-title":"Blood"},{"key":"262_CR54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1074\/jbc.M808010200","volume":"284","author":"MA Sanders","year":"2009","unstructured":"Sanders MA, Ampasala D, Basson MD. DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV. J Biol Chem. 2009;284:27\u201335.","journal-title":"J Biol Chem"},{"key":"262_CR55","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0955-0674(96)80102-5","volume":"8","author":"R Timpl","year":"1996","unstructured":"Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol. 1996;8:618\u201324.","journal-title":"Curr Opin Cell Biol"},{"key":"262_CR56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1083\/jcb.200505018","volume":"171","author":"M Yoshigi","year":"2005","unstructured":"Yoshigi M, Hoffman LM, Jensen CC, Yost HJ, Beckerle MC. Mechanical force mobilizes zyxin from focal adhesions to actin filaments and regulates cytoskeletal reinforcement. J Cell Biol. 2005;171:209\u201315.","journal-title":"J Cell Biol"},{"key":"262_CR57","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1038\/sj.onc.1210762","volume":"26","author":"AN Goldfarb","year":"2007","unstructured":"Goldfarb AN. Transcriptional control of megakaryocyte development. Oncogene. 2007;26:6795\u2013802.","journal-title":"Oncogene"},{"key":"262_CR58","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/MCB.23.4.1390-1402.2003","volume":"23","author":"J Starck","year":"2003","unstructured":"Starck J, Cohet N, Gonnet C, Sarrazin S, Doubeikovskaia Z, Doubeikovski A, et al. Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol. 2003;23:1390\u2013402.","journal-title":"Mol Cell Biol"},{"key":"262_CR59","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2014-11-610519","volume":"125","author":"ON Kuvardina","year":"2015","unstructured":"Kuvardina ON, Herglotz J, Kolodziej S, Kohrs N, Herkt S, Wojcik B, et al. RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation. Blood. 2015;125:3570\u20139.","journal-title":"Blood"},{"key":"262_CR60","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1073\/pnas.93.5.1935","volume":"93","author":"MC Ghozi","year":"1996","unstructured":"Ghozi MC, Bernstein Y, Negreanu V, Levanon D, Groner Y. Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc Natl Acad Sci USA. 1996;93:1935\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"262_CR61","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1038\/sj.onc.1207670","volume":"23","author":"D Levanon","year":"2004","unstructured":"Levanon D, Groner Y. Structure and regulated expression of mammalian RUNX genes. Oncogene. 2004;23:4211\u20139.","journal-title":"Oncogene"},{"key":"262_CR62","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1182\/blood-2008-12-193003","volume":"113","author":"T Bee","year":"2009","unstructured":"Bee T, Ashley EL, Bickley SR, Jarratt A, Li PS, Sloane-Stanley J, et al. The mouse Runx1 +23 hematopoietic stem cell enhancer confers hematopoietic specificity to both Runx1 promoters. Blood. 2009;113:5121\u20134.","journal-title":"Blood"},{"key":"262_CR63","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2010-07-295113","volume":"117","author":"N Pencovich","year":"2011","unstructured":"Pencovich N, Jaschek R, Tanay A, Groner Y. Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models. Blood. 2011;117:e1\u201314.","journal-title":"Blood"},{"key":"262_CR64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm997","volume":"10","author":"M Ichikawa","year":"2004","unstructured":"Ichikawa M, Asai T, Saito T, Seo S, Yamazaki I, Yamagata T, et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med. 2004;10:299\u2013304.","journal-title":"Nat Med"},{"key":"262_CR65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13748-8","volume":"7","author":"J Marsman","year":"2017","unstructured":"Marsman J, Thomas A, Osato M, O\u2019Sullivan JM, Horsfield JAA. DNA contact map for the mouse Runx1 gene identifies novel haematopoietic enhancers. Sci Rep. 2017;7:13347.","journal-title":"Sci Rep"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-00262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-00262-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-00262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T08:26:57Z","timestamp":1630657617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-020-00262-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1038\/s41417-020-00262-9","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"29 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}